Bilitranslocase is involved in the uptake of bromosulfophthalein in Rat and Human Liver

Drug Metabolism Letters

Volumn 6, Issue 3, 2012, Pages 165-173

  Terdoslavich, Michela ^a   de Graaf, Inge A M ^b   Proost, Johannes H ^b   Cocolo, Alessandra ^a   Passamonti, Sabina ^a   Groothuis, Geny M M ^b  

^a UNIVERSITY OF TRIESTE   (Italy)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Bilirubin; Bilitranslocase; Bromosulfophthalein; Digoxin; Indocyanine green; Liver slices; Membrane transport; Taurocholate

Indexed keywords

ANTIBODY; BILIRUBIN; BILITRANSLOCASE; BILITRANSLOCASE ANTIBODY; BROMSULFOPHTHALEIN; DIGOXIN; ORGANIC ANION TRANSPORTER; TAUROCHOLIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOTRANSFORMATION; DRUG UPTAKE; ENZYME INDUCTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER SLICE; LIVER TOXICITY; MEMBRANE TRANSPORT; MULTIGENE FAMILY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIBODIES; BIOLOGICAL TRANSPORT; HUMANS; LIVER; MALE; MEMBRANE PROTEINS; RATS; RATS, WISTAR; SPECIES SPECIFICITY; SULFOBROMOPHTHALEIN; TAUROCHOLIC ACID; TEMPERATURE;

RATTUS;

EID: 84876735913     PISSN: 18723128     EISSN: None     Source Type: Journal    
DOI: 10.2174/1872312811206030003     Document Type: Article

References (50)

1. McDonagh, A. Controversies in bilirubin biochemistry and their clinical relevance. Semin. Fetal Neonatal. Med., 2010, 15, 141-147.
2. Sakka, S.G. Assessing liver function. Curr. Opin. Crit. Care, 2007, 13, 207-214.
3. Goresky, C.A. The Hepatic Uptake and Excretion of Sulfobromophthalein and Bilirubin. Can. Med. Assoc. J., 1965, 92, 851-857.
4. Scharschmidt, B.F.; Waggoner, J.G.; Berk, P.D. Hepatic organic anion uptake in the rat. J. Clin. Invest., 1975, 56, 1280-1292.
5. Meier, P.J.; Eckhardt, U.; Schroeder, A.; Hagenbuch, B.; Stieger, B. Substrate specificity of sinusoidal bile acid and organic anion uptake systems in rat and human liver. Hepatology, 1997, 26, 1667-1677.
6. Hata, S.; Wang, P.; Eftychiou, N.; Ananthanarayanan, M.; Batta, A.; Salen, G.; Pang, K.S.; Wolkoff, A.W. Substrate specificities of rat oatp1 and ntcp: implications for hepatic organic anion uptake. Am. J. Physiol. Gastrointest. Liver Physiol., 2003, 285, G829-839.
7. Shin, H.J.; Anzai, N.; Enomoto, A.; He, X.; Kim do, K.; Endou, H.; Kanai, Y. Novel liver-specific organic anion transporter OAT7 that operates the exchange of sulfate conjugates for short chain fatty acid butyrate. Hepatology, 2007, 45, 1046-1055.
8. Torres, A.; Lunazzi, G.; Stremmel, W.; Tiribelli, C. Bilitranslocase and sulfobromophthalein/bilirubin-binding protein are both involvedin the hepatic uptake of organic anions. Proc. Natl. Acad. Sci. USA, 1993, 90, 8136-8139.
9. Saier, M.H., Jr. A functional-phylogenetic classification system for transmembrane solute transporters. Microbiol. Mol. Biol. Rev., 2000, 64, 354-411.
10. Sottocasa, G.L.; Passamonti, S.; Battiston, L.; Pascolo, L.; Tiribelli, C. Molecular aspects of organic anion uptake in liver. J. Hepatol., 1996, 24, 36-41.
11. Passamonti, S.; Terdoslavich, M.; Margon, A.; Cocolo, A.; Medic, N.; Micali, F.; Decorti, G.; Franko, M. Uptake of bilirubin into HepG2 cells assayed by thermal lens spectroscopy. FEBS J., 2005, 272, 5522-5535.
12. Passamonti, S.; Tramer, F.; Petrussa, E.; Braidot, E.; Vianello, A. Bioavailability of flavonoids: a review of their membrane transport and the function of bilitranslocase in animal and plant organisms. Curr. Drug Metab., 2009, 10, 369-394.
13. Passamonti, S.; Vanzo, A.; Vrhovsek, U.; Terdoslavich, M.; Cocolo, A.; Decorti, G.; Mattivi, F. Hepatic uptake of grape anthocyanins and the role of bilitranslocase. Food Res. Int., 2005, 38, 953-960.
14. Maestro, A.; Terdoslavich, M.; Vanzo, A.; Kuku, A.; Tramer, F.; Nicolin, V.; Micali, F.; Decorti, G.; Passamonti, S. Expression of bilitranslocase in the vascular endothelium and its function as a flavonoid transporter. Cardiovasc. Res., 2010, 85, 175-183.
15. Ziberna, L.; Lunder, M.; Tramer, F.; Drevensek, G.; Passamonti, S. The endothelial plasma membrane transporter bilitranslocase mediates rat aortic vasodilation induced by anthocyanins. Nutr. Metab. Cardiovasc. Dis., 2011, May 4. [Epub ahead of print].
16. Ziberna, L.; Tramer, F.; Moze, S.; Vrhovsek, U.; Mattivi, F.; Passamonti, S. Transport and Bioactivity of Cyanidin 3-Glucoside into the Vascular Endothelium. Free Radic. Biol. Med., 2012, 52, 1750-1759.
17. Ball, S.E.; Thiel, V.E.; Tio, C.O.; Lim, H.K.; Kao, J.; Sisenwine, S. F.; Scatina, J. [14C]7-ethoxycoumarin metabolism by precision-cut rat hepatic slices. Drug Metab. Dispos., 1996, 24, 383-389.
18. Dogterom, P.; Rothuizen, J. A species comparison of tolbutamide metabolism in precision-cut liver slices from rats and dogs. Qualitative and quantitative sex differences. Drug Metab. Dispos., 1993, 21, 705-709.
19. Hashemi, E.; Dobrota, M.; Till, C.; Ioannides, C. Structural and functional integrity of precision-cut liver slices in xenobiotic metabolism: a comparison of the dynamic organ and multiwell plate culture procedures. Xenobiotica, 1999, 29, 11-25.
20. Hofmann, A.F.; Zakko, S.F.; Lira, M.; Clerici, C.; Hagey, L.R.; Lambert, K.K.; Steinbach, J.H.; Schteingart, C.D.; Olinga, P.; Groothuis, G.M. Novel biotransformation and physiological properties of norursodeoxycholic acid in humans. Hepatology, 2005, 42, 1391-1398.
21. Miller, M.G.; Beyer, J.; Hall, G.L.; deGraffenried, L.A.; Adams, P.E. Predictive value of liver slices for metabolism and toxicity in vivo: use of acetaminophen as a model hepatotoxicant. Toxicol. Appl. Pharmacol., 1993, 122, 108-116.
22. Wang, Y.F.; Hu, M.L. Use of rat liver slices for the study of oxidative DNA damage in comparison with isolated rat liver nuclei and HepG2 human hepatoma cells. Food Chem. Toxicol., 2000, 38, 451-458.
23. Lake, B.G.; Ball, S.E.; Renwick, A.B.; Tredger, J.M.; Kao, J.; Beamand, J.A.; Price, R.J. Induction of CYP3A isoforms in cultured precision-cut human liver slices. Xenobiotica, 1997, 27, 1165-1173.
24. Elferink, M.G.; Olinga, P.; Draaisma, A.L.; Merema, M.T.; Faber, K.N.; Slooff, M.J.; Meijer, D.K.; Groothuis, G.M. LPS-induced downregulation of MRP2 and BSEP in human liver is due to a posttranscriptional process. Am. J. Physiol. Gastrointest. Liver Physiol., 2004, 287, G1008-1016.
25. Olinga, P.; Hof, I.H.; Merema, M.T.; Smit, M.; de Jager, M.H.; Swart, P.J.; Slooff, M.J.; Meijer, D.K.; Groothuis, G.M. The applicability of rat and human liver slices to the study of mechanisms of hepatic drug uptake. J. Pharmacol. Toxicol. Methods, 2001, 45, 55-63.
26. Camenisch, G.; Umehara, K.I. Predicting human hepatic clearance from in vitro drug metabolism and transport data: A scientific and pharmaceutical perspective for assessing drug-drug interactions. Biophanrm. Drug. Dispos., 2012, 33, 179-194.
27. Dobson, P.D.; Lanthaler, K.; Oliver, S.G.; Kell, D.B. Implications of the dominant role of transporters in drug uptake by cells. Curr. Top. Med. Chem., 2009, 9, 163-181.
28. Battiston, L.; Passamonti, S.; Macagno, A.; Sottocasa, G.L. The bilirubin-binding motif of bilitranslocase and its relation to conserved motifs in ancient biliproteins. Biochem. Biophys. Res. Commun., 1998, 247, 687-692.
29. Passamonti, S.; Cocolo, A.; Braidot, E.; Petrussa, E.; Peresson, C.; Medic, N.; Macri, F.; Vianello, A. Characterization of electrogenic bromosulfophthalein transport in carnation petal microsomes and its inhibition by antibodies against bilitranslocase. FEBS J., 2005, 272, 3282-3296.
30. Passamonti, S.; Tramer, F.; Petrussa, E.; Braidot, E.; Vianello, A. Electrogenic bromosulfalein transport in isolated membrane vesicles: implementation in both animal and plant preparations for the study of flavonoid transporters. In: Plant Secondary Metabolism Engineering, Methods in Molecular Biology; Fett-Neto, A.G., Ed.; Humana Press Inc.: Totowa, NJ, 2010; Vol. 643, pp. 307-336.
31. Passamonti, S.; Battiston, L.; Sottocasa, G.L. Arylsulfonylation of bilitranslocase in plasma membranes from rat liver enables to discriminate between natural and artificial substrates. Biochim. Biophys. Acta, 1997, 1323, 130-136.
32. Passamonti, S.; Battiston, L.; Sottocasa, G.L. Bilitranslocase can exist in two metastable forms with different affinities for the substrates--evidence from cysteine and arginine modification. Eur. J. Biochem., 1998, 253, 84-90.
33. van Montfoort, J.E.; Hagenbuch, B.; Groothuis, G.M.; Koepsell, H.; Meier, P.J.; Meijer, D.K. Drug uptake systems in liver and kidney. Curr. Drug Metab., 2003, 4, 185-211.
34. De Graaf, I.; Olinga, P.; De Jager, M.H.; Merema, M.T.; de Kanter, R.; van de Kerkhof, E.G.; Groothuis, G.M. Preparation and incubation of precision-cut liver and intestinal slices for application in drug metabolism and toxicity studies. Nat. Protoc., 2010, 5, 1540-1551.
35. Olinga, P.; Merema, M.; Hof, I.H.; de Jong, K.P.; Slooff, M.J.; Meijer, D.K.; Groothuis, G.M. Effect of human liver source on the functionality of isolated hepatocytes and liver slices. Drug Metab. Dispos., 1998, 26, 5-11.
36. Plazar, J.; Hreliac, I.; Pirih, P.; Filipic, M.; Groothuis, G.M. Detection of xenobiotic-induced DNA damage by the comet assay applied to human and rat precision-cut liver slices. Toxicol. in Vitro, 2007, 21, 1134-1142.
37. Worboys, P.D.; Bradbury, A.; Houston, J.B. Kinetics of drug metabolism in rat liver slices. III. Relationship between metabolic clearance and slice uptake rate. Drug Metab. Dispos., 1997, 25, 460-467.
38. Statistical description of the quality of processes and measurements. In: Data Handling in Science and Technology; Massart, D.L.; Vandeginste, B.G.M.; Buydens, L.M.C.; De Jong, S.; Lewi, P.J.; Smeyers-Verbeke, J., Eds. Elsevier Science B.V.: Amsterdam, 1997; Vol. 20, pp 21-46.
39. Cattori, V.; van Montfoort, J.E.; Stieger, B.; Landmann, L.; Meijer, D.K.; Winterhalter, K.H.; Meier, P.J.; Hagenbuch, B. Localization of organic anion transporting polypeptide 4 (Oatp4) in rat liver and comparison of its substrate specificity with Oatp1, Oatp2 and Oatp3. Pflugers Arch., 2001, 443, 188-195.
40. Kullak-Ublick, G.A.; Ismair, M.G.; Stieger, B.; Landmann, L.; Huber, R.; Pizzagalli, F.; Fattinger, K.; Meier, P.J.; Hagenbuch, B. Organic anion-transporting polypeptide B (OATP-B) and its functional comparison with three other OATPs of human liver. Gastroenterology, 2001, 120, 525-533.
41. Nijssen, H.M.; Pijning, T.; Meijer, D.K.; Groothuis, G.M. Mechanistic aspects of uptake and sinusoidal efflux of dibromosulfophthalein in the isolated perfused rat liver. Biochem. Pharmacol., 1991, 42, 1997-2002.
42. Morita, N.; Kusuhara, H.; Sekine, T.; Endou, H.; Sugiyama, Y. Functional characterization of rat organic anion transporter 2 in LLC-PK1 cells. J. Pharmacol. Exp. Ther., 2001, 298, 1179-1184.
43. Kusuhara, H.; Sekine, T.; Utsunomiya-Tate, N.; Tsuda, M.; Kojima, R.; Cha, S.H.; Sugiyama, Y.; Kanai, Y.; Endou, H. Molecular cloning and characterization of a new multispecific organic anion transporter from rat brain. J. Biol. Chem., 1999, 274, 13675-13680.
44. Smith, N.F.; Figg, W.D.; Sparreboom, A. Role of the liver-specific transporters OATP1B1 and OATP1B3 in governing drug elimination. Expert Opin. Drug Metab. Toxicol., 2005, 1, 429-445.
45. Cui, Y.; Konig, J.; Leier, I.; Buchholz, U.; Keppler, D. Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6. J. Biol. Chem., 2001, 276, 9626-9630.
46. Olynyk, J.K.; Clarke, S.L. Isolation and primary culture of rat Kupffer cells. J. Gastroenterol. Hepatol., 1998, 13, 842-845.
47. Ahlfors, C.E. Bilirubin-albumin binding and free bilirubin. J. Perinatol., 2001, 21 Suppl 1, S40-42; discussion S59-62.
48. Gentile, S.; Tiribelli, C.; Persico, M.; Bronzino, P.; Marmo, R.; Orzes, N.; Orlando, C.; Rubba, P.; Coltorti, M. Dose dependence of nicotinic acid-induced hyperbilirubinemia and its dissociation from hemolysis in Gilbert's syndrome. J. Lab. Clin. Med., 1986, 107, 166-171.
49. Passamonti, S.; Sottocasa, G.L. The quinoid structure is the molecular requirement for recognition of phthaleins by the organic anion carrier at the sinusoidal plasma membrane level in the liver. Biochim. Biophys. Acta, 1988, 943, 119-125.
50. Zuperl, S.; Fornasaro, S.; Novic, M.; Passamonti, S. Experimental determination and prediction of bilitranslocase transport activity. Anal. Chim. Acta, 2011, 705, 322-333.